125 related articles for article (PubMed ID: 38252655)
1. Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan.
Nesbitt RC; Asilaza VK; Gignoux E; Koyuncu A; Gitahi P; Nkemenang P; Duncker J; Antier Z; Haile M; Gakima P; Wamala JF; Loro FB; Biem D; Rull M; Azman AS; Rumunu J; Ciglenecki I
PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011661. PubMed ID: 38252655
[TBL] [Abstract][Full Text] [Related]
2. The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey.
Ngwa MC; Alemu W; Okudo I; Owili C; Ugochukwu U; Clement P; Devaux I; Pezzoli L; Oche JA; Ihekweazu C; Sack DA
BMJ Glob Health; 2020 Jun; 5(6):. PubMed ID: 32601092
[TBL] [Abstract][Full Text] [Related]
3. Reactive and pre-emptive vaccination strategies to control hepatitis E infection in emergency and refugee settings: A modelling study.
Cooper BS; White LJ; Siddiqui R
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006807. PubMed ID: 30252843
[TBL] [Abstract][Full Text] [Related]
4. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand.
Phares CR; Date K; Travers P; Déglise C; Wongjindanon N; Ortega L; Bhuket PR
Vaccine; 2016 Jan; 34(1):128-33. PubMed ID: 26549363
[TBL] [Abstract][Full Text] [Related]
5. Integrating immunisation services into nutrition sites to improve immunisation status of internally displaced persons' children living in Bentiu protection of civilian site, South Sudan.
Oladeji O; Campbell P; Jaiswal C; Chamla D; Oladeji B; Ajumara CO; Minguiel LM; Senesie J
Pan Afr Med J; 2019; 32():28. PubMed ID: 31143333
[TBL] [Abstract][Full Text] [Related]
6. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh.
Zaman K; Dudman S; Stene-Johansen K; Qadri F; Yunus M; Sandbu S; Gurley ES; Overbo J; Julin CH; Dembinski JL; Nahar Q; Rahman A; Bhuiyan TR; Rahman M; Haque W; Khan J; Aziz A; Khanam M; Streatfield PK; Clemens JD
BMJ Open; 2020 Jan; 10(1):e033702. PubMed ID: 31959609
[TBL] [Abstract][Full Text] [Related]
7. Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons--Liberia, 2004.
Huhn GD; Brown J; Perea W; Berthe A; Otero H; LiBeau G; Maksha N; Sankoh M; Montgomery S; Marfin A; Admassu M
Vaccine; 2006 Feb; 24(6):730-7. PubMed ID: 16182416
[TBL] [Abstract][Full Text] [Related]
8. High Hepatitis E Seroprevalence Among Displaced Persons in South Sudan.
Azman AS; Bouhenia M; Iyer AS; Rumunu J; Laku RL; Wamala JF; Rodriguez-Barraquer I; Lessler J; Gignoux E; Luquero FJ; Leung DT; Gurley ES; Ciglenecki I
Am J Trop Med Hyg; 2017 Jun; 96(6):1296-1301. PubMed ID: 28719276
[TBL] [Abstract][Full Text] [Related]
9. Investigation of hepatitis E outbreak among refugees - Upper Nile, South Sudan, 2012-2013.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jul; 62(29):581-6. PubMed ID: 23884344
[TBL] [Abstract][Full Text] [Related]
10. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan.
Boccia D; Guthmann JP; Klovstad H; Hamid N; Tatay M; Ciglenecki I; Nizou JY; Nicand E; Guerin PJ
Clin Infect Dis; 2006 Jun; 42(12):1679-84. PubMed ID: 16705571
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
[TBL] [Abstract][Full Text] [Related]
13. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
Glover C; Crawford N; Leeb A; Wood N; Macartney K
Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological characterization of COVID-19 in displaced populations of South Sudan.
Wamala JF; Loro F; Deng SJ; Berta KK; Guyo AG; Mpairwe A; Ndenzako F; Rumunu JP
Pan Afr Med J; 2022; 42(Suppl 1):4. PubMed ID: 36158931
[TBL] [Abstract][Full Text] [Related]
15. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
16. [Impact of Controlled Temperature Chain (CTC) approach on immunization coverage achieved during the preventive vaccination campaign against meningitis A using MenAfriVac in Togo in 2014].
Landoh DE; Kahn AL; Lacle A; Adjeoda K; Saka B; Yaya I; Nassoury DI; Kalao A; Makawa MS; Biey NJ; Bita A; Toke YT; Dörte P; Imboua L; Ronveaux O
Pan Afr Med J; 2017; 27():38. PubMed ID: 28761614
[TBL] [Abstract][Full Text] [Related]
17. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccination during pregnancy: coverage and safety.
Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
[TBL] [Abstract][Full Text] [Related]
20. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
